X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19) 19
female (17) 17
male (16) 16
adult (15) 15
middle aged (14) 14
index medicus (12) 12
hematology (11) 11
aged (10) 10
imatinib mesylate (8) 8
adolescent (7) 7
antineoplastic agents - therapeutic use (6) 6
benzamides (6) 6
chronic myeloid leukemia (5) 5
hemic and lymphatic diseases (5) 5
imatinib (5) 5
leukemia, myelogenous, chronic, bcr-abl positive - genetics (5) 5
piperazines - therapeutic use (5) 5
prognosis (5) 5
pyrimidines - therapeutic use (5) 5
systemic mastocytosis (5) 5
therapy (5) 5
treatment outcome (5) 5
young adult (5) 5
adults (4) 4
aged, 80 and over (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
leukemia (4) 4
mastocytosis, systemic - diagnosis (4) 4
mutation (4) 4
retrospective studies (4) 4
biomarker (3) 3
cell activation syndromes (3) 3
classification (3) 3
diagnosis (3) 3
follow-up studies (3) 3
fusion proteins, bcr-abl - genetics (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (3) 3
mast cell disease (3) 3
mast-cells (3) 3
mastocytosis (3) 3
oncology (3) 3
piperazines - administration & dosage (3) 3
protein-tyrosine kinases - antagonists & inhibitors (3) 3
pyrimidines - administration & dosage (3) 3
recurrence (3) 3
remission induction (3) 3
reverse transcriptase polymerase chain reaction (3) 3
skin (3) 3
abridged index medicus (2) 2
antineoplastic agents - administration & dosage (2) 2
biopsy (2) 2
blast crisis (2) 2
bone marrow - pathology (2) 2
cancer (2) 2
care and treatment (2) 2
chronic myelogenous leukemia (2) 2
chronic myeloid-leukemia (2) 2
cml patients (2) 2
cross-sectional studies (2) 2
delineation (2) 2
dendritic cells (2) 2
diagnostic criteria (2) 2
diagnostic-criteria (2) 2
disease (2) 2
disease activity (2) 2
disorders (2) 2
fusion gene transcripts (2) 2
hypereosinophilic syndrome (2) 2
hypereosinophilic syndrome - genetics (2) 2
immunology (2) 2
interferon (2) 2
kit (2) 2
lymphatic system (2) 2
management (2) 2
mastocytosis, cutaneous - pathology (2) 2
mastocytosis, systemic - genetics (2) 2
medical prognosis (2) 2
medical research (2) 2
medicine, experimental (2) 2
mesylate (2) 2
mutations (2) 2
protein kinase inhibitors - administration & dosage (2) 2
proto-oncogene proteins c-kit - genetics (2) 2
receptor for the advanced glycation end products (2) 2
remission (2) 2
survival rate (2) 2
time factors (2) 2
tumors (2) 2
ulcerative colitis (2) 2
who classification (2) 2
1524 (1) 1
175 (1) 1
177 (1) 1
5-hydroxymethylation (1) 1
5-methylcytosine (1) 1
51-70 years (1) 1
5‐hydroxymethylation (1) 1
accelerated phase (1) 1
acquired immunodeficiency syndrome - complications (1) 1
acquired immunodeficiency syndrome - metabolism (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Hematology, ISSN 0361-8609, 07/2016, Volume 91, Issue 7, pp. 692 - 699
Journal Article
Blood, ISSN 0006-4971, 2009, Volume 114, Issue 10, pp. 2168 - 2171
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2006, Volume 12, Issue 10, pp. 3037 - 3042
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 4543 - 4543
Abstract Imatinib (IM) is a cornerstone in the treatment of chronic myeloid leukemia (CML). Dose change or discontinuation of IM in patients who experience... 
Journal Article
American Journal of Hematology, ISSN 0361-8609, 02/2014, Volume 89, Issue 2, pp. 119 - 124
Journal Article
The Journal of Allergy and Clinical Immunology: In Practice, ISSN 2213-2198, 01/2019, Volume 7, Issue 1, pp. 81 - 87
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 3136 - 3136
Abstract Background and Aim Systemic mastocytosis (SM) is characterized by a heterogeneous spectrum of disease variants with different clinical features and... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 4085 - 4085
Abstract Background and Aims: The term Systemic Mastocytosis (SM) identifies a poorly understood group of rare and clinically heterogenous myeloproliferative... 
Journal Article